Suggested Topics within your search.
Suggested Topics within your search.
- methods 5
- Therapeutic use 4
- therapeutic use 4
- Anesthesia 3
- Anesthetics 3
- therapy 3
- Anesthesiology 2
- Biochemistry 2
- Chemistry, Clinical 2
- Chemotherapy 2
- Cognitive Therapy 2
- Health and Fitness 2
- Pharmacology 2
- pharmacology 2
- Analgesia 1
- Analgesics 1
- Anti-Infective Agents 1
- Anti-infective agents 1
- Anxiety Disorders 1
- Child welfare 1
- Clinical Chemistry Tests 1
- Clinical chemistry 1
- Cognitive therapy 1
- Communicable diseases in children 1
- Congresses 1
- Cultural Diversity 1
- Custody of children 1
- Diarrhea, Infantile 1
- Diet therapy 1
- Diet therapy for infants 1
-
2601
CXC Chemokines in the Pathogenesis of Pulmonary Disease and Pharmacological Relevance
Published 2022-01-01“…The potential therapeutic benefits of pharmacological or other CXCL/CXCR axis manipulations are also discussed.…”
Get full text
Article -
2602
-
2603
Increasing brain half-life of antibodies by additional binding to myelin oligodendrocyte glycoprotein, a CNS specific protein
Published 2025-01-01“…The most well-studied approach to enhance brain influx of protein therapeutics, is receptor-mediated transcytosis (RMT) by targeting nutrient receptors to shuttle protein therapeutics over the blood–brain barrier (BBB) along with their endogenous cargos. …”
Get full text
Article -
2604
Bacterial metabolism in the host and its association with virulence
Published 2025-12-01“…The knowledge of crosslinked metabolic pathways of bacteria and their host will serve to develop novel potential therapeutics.…”
Get full text
Article -
2605
Hsp104 suppresses polyglutamine-induced degeneration post onset in a drosophila MJD/SCA3 model.
Published 2013-01-01“…There are no effective therapeutics that antagonize or reverse the protein-misfolding events underpinning polyglutamine (PolyQ) disorders, including Spinocerebellar Ataxia Type-3 (SCA3). …”
Get full text
Article -
2606
Artificial intelligence (AI) or augmented intelligence? How big data and AI are transforming healthcare: Challenges and opportunities
Published 2023-12-01“…A transformed healthcare environment enhanced by innovation, robotics, digital technology, and improved diagnostics and therapeutics is plagued by ethical, legal and social challenges. …”
Get full text
Article -
2607
-
2608
Molecular and cellular characteristics of cerebrovascular cell types and their contribution to neurodegenerative diseases
Published 2025-01-01“…Abstract Many diseases and disorders of the nervous system suffer from a lack of adequate therapeutics to halt or slow disease progression, and to this day, no cure exists for any of the fatal neurodegenerative diseases. …”
Get full text
Article -
2609
ABO Blood Groups and Cardiovascular Diseases
Published 2012-01-01“…The role of blood group antigens in the pathogenesis of various cardiovascular disorders remains a fascinating subject with potential to lead to novel therapeutics and prognostics and to reduce the global burden of cardiovascular diseases.…”
Get full text
Article -
2610
Physiological Roles of DNA Double-Strand Breaks
Published 2017-01-01“…Growing evidence points to a role of aberrant DSB physiology in human disease and an understanding of these processes may both inform the design of new therapeutic strategies and reduce off-target effects of existing drugs. …”
Get full text
Article -
2611
-
2612
A pan-orthohantavirus human lung xenograft mouse model and its utility for preclinical studies.
Published 2025-01-01“…Here, we describe the use of a human lung xenograft mouse model to study the permissiveness for different orthohantavirus species and to assess its utility for preclinical testing of therapeutics. Following infection of xenografted human lung tissues, distinct orthohantavirus species differentially replicated in the human lung and subsequently spread systemically. …”
Get full text
Article -
2613
Neuromuscular diseases: genomics-driven advances
Published 2024-11-01“…Continued progress in gene therapy, RNA-based therapeutics, and personalized medicine holds promise for further breakthroughs in the management of these debilitating diseases.…”
Get full text
Article -
2614
Comprehensive genome-scale CRISPR knockout screening of CHO cells
Published 2025-01-01“…Abstract Chinese hamster ovary (CHO) cells play a pivotal role in the production of recombinant therapeutics. In the present study, we conducted a genome-scale pooled CRISPR knockout (KO) screening using a virus-free, recombinase-mediated cassette exchange-based platform in CHO-K1 host and CHO-K1 derived recombinant cells. …”
Get full text
Article -
2615
-
2616
Molecular glue degrader for tumor treatment
Published 2024-12-01“…Given that molecular glue research is still in its early stage, we summarized the mechanisms of molecular glue, the promising drugs in clinical trials and diverse feasible design strategies for molecular glue therapeutics.…”
Get full text
Article -
2617
Nanocurcumin in myocardial infarction therapy: emerging trends and future directions
Published 2025-01-01“…Research and clinical trials are essential for comprehensive analysis and efficacy of curcumin-based nano-therapeutics in cardiovascular condition and lowering risk of MI.…”
Get full text
Article -
2618
An Audit of Pain Management Following Pediatric Day Surgery at British Columbia Children’s Hospital
Published 2012-01-01Get full text
Article -
2619
Excisional Biopsy of the Pyogenic Granuloma in Very High-Risk Patient
Published 2018-01-01Get full text
Article -
2620
Repository Corticotropin Injection for Treatment of Idiopathic Inflammatory Myopathies
Published 2016-01-01“…There are few approved therapeutics available for treatment of this group of diseases and the first-line therapy is usually corticosteroid treatment. …”
Get full text
Article